ADAM10 and Alzheimer disease: However, experiments by Shackleton, Crawford & Bachmeier (2016) suggested that inhibition of ADAM10 promoted the clearance of Aβ1–40 and Aβ1–42 in the brains of mice with AD, thereby reducing the level of Aβ.